Biontech

Biontech's reported carbon emissions

In 2025, BioNTech reported total greenhouse gas emissions of approximately 711.6 million kg CO2e, comprising 2,209,000 kg CO2e from Scope 1 and 703,634,000 kg CO2e from Scope 3 emissions. Notably, Scope 2 emissions were reported as zero, indicating a potential reliance on renewable energy sources or a lack of data. The company has set an ambitious target to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2021 as the baseline year. This commitment aligns with the Science Based Targets initiative (SBTi) requirements, aiming to ensure that 72% of its suppliers, covering purchased goods and services, capital goods, and upstream transportation and distribution, will also have science-based targets by 2027. In previous years, BioNTech's emissions were as follows: in 2024, total emissions were approximately 892.9 million kg CO2e, with Scope 1 emissions at 2,415,000 kg CO2e and Scope 3 emissions at 886,448,000 kg CO2e. In 2023, total emissions were about 534.2 million kg CO2e, with Scope 1 emissions of 1,342,000 kg CO2e and Scope 3 emissions of 529,501,000 kg CO2e. BioNTech's commitment to reducing emissions reflects its proactive approach to climate responsibility within the pharmaceutical and biotechnology sector, aiming to contribute positively to global climate goals.